The report Dental biomaterials market by product type (Metallic Biomaterial, Ceramic Biomaterial, Metal-ceramic biomaterial, and natural biomaterial). Application (Biomaterials in Implantology, Biomaterials in Prosthodontics, Biomaterials in Orthodontics), End-user (Dental Product Manufacturers, Dental Laboratories, Dental Hospitals and Clinics, Dental academics, and research institutes) and Region. Global Forecast to 2030-." the global Dental Biomaterials market share was USD 7.18 billion in 2020. It is predicted to reach USD 14.5 billion by 2030, representing a CAGR of 7.29 percent throughout the forecasted period".
To know more about the report, Click on the link :- https://www.strategicmarketresearch.com/market-report/dental-biomaterials-market
KEY FACTORS AUGMENTING THE MARKET GROWTH
Some of the most notable factors that are majorly driving the market's overall growth worldwide are an increase in dental disorders such as periodontal disease, tooth decay, oral cancer, dental caries, and halitosis, among all other diseases and the demand for dental tourism due to its affordability which can overall increase the adoption of dental procedures among the targeted patient audience. With large investments in advanced dental biomaterials, the government is focusing on research and development of the global dental biomaterials market, which can create ample opportunities for the market's overall growth in the coming years.
Based on Type, the metallic biomaterials segment dominated the overall market share in 2020
In terms of the product type, the global dental biomaterials market has been broadly classified into Metallic Biomaterial, Ceramic Biomaterial, Metal- ceramic Biomaterials, and Natural Biomaterials. Metallic biomaterials are segmented into Titanium, Stainless steel, and Chromium alloys. With an emphasis on increasing the penetration of dental implants, high strength of materials, and wide applications of metallic biomaterials in dentistry, the metallic biomaterials segment dominated the overall market.
Based on Application, the Biomaterials in the implantology segment dominated the overall market share in 2020
Based on the Application, the Global dental biomaterials market has been broadly classified into Biomaterials in Implantology, Biomaterials in Prosthodontics, and Biomaterials in Orthodontics. The Biomaterials in the implantology segment dominated the overall market due to the increase in the penetration of global dental implants, increased demand for cosmetic dentistry, high price and volume requirements, and growing dental tourism in emerging markets.
Based on End-user, the Dental laboratories segment dominated the overall market share in 2020
Based on End-user, the Global dental biomaterials market has been broadly classified into Dental Product Manufacturers, Dental Laboratories, Dental Hospitals and Clinics, and Dental academics and research institutes. The Dental laboratories segment dominated the market with a significant market share in the forecasted period with a steady CAGR which is attributed to the increase in dental practice, increase in tooth disorders, and general awareness about oral hygiene.
Based on Region, North America accounts for the dominant market share in 2020
Based on Region, the Global dental biomaterials market has been broadly classified into North America< Europe, Asia-Pacific, and LAMEA. North America has occupied the largest market, with the US observing significant growth with a steady CAGR during the forecasted period. The factors responsible for the development are the increase in the product launches with the government's support, an increase in the burden of dental disorders, and a large no of geriatric population.
Key Competitive Players
The key players included in the Global Dental Biomaterials market include 3M company, Carpenter Technology Corporation, Royal DSM, Zimmer Biomet Holdings Inc, Straumann Holding AG, Danaher Corporation, Kuraray Co Ltd, Henry Schein Inc, Mitsui Chemicals Inc, Victrex PLC, Geistlich Pharma AG, Dentsply Sirona Inc, Medtronic PLC, Ivoclar Vivadent AG, GC Corporation.
Recent Developments